作者
Hitoshi Suzuki, Zina Moldoveanu, Stacy Hall, Rhubell Brown, Huong L Vu, Lea Novak, Bruce A Julian, Milan Tomana, Robert J Wyatt, Jeffrey C Edberg, Graciela S Alarcón, Robert P Kimberly, Yasuhiko Tomino, Jiri Mestecky, Jan Novak
发表日期
2008/2/1
期刊
The Journal of clinical investigation
卷号
118
期号
2
页码范围
629-639
出版商
American Society for Clinical Investigation
简介
Aberrant glycosylation of IgA1 plays an essential role in the pathogenesis of IgA nephropathy. This abnormality is manifested by a deficiency of galactose in the hinge-region O-linked glycans of IgA1. Biosynthesis of these glycans occurs in a stepwise fashion beginning with the addition of N-acetylgalactosamine by the enzyme N-acetylgalactosaminyltransferase 2 and continuing with the addition of either galactose by β1,3-galactosyltransferase or a terminal sialic acid by a N-acetylgalactosamine–specific α2,6-sialyltransferase. To identify the molecular basis for the aberrant IgA glycosylation, we established EBV-immortalized IgA1-producing cells from peripheral blood cells of patients with IgA nephropathy. The secreted IgA1 was mostly polymeric and had galactose-deficient O-linked glycans, characterized by a terminal or sialylated N-acetylgalactosamine. As controls, we showed that EBV-immortalized cells from …
引用总数
2008200920102011201220132014201520162017201820192020202120222023202452122323321321526142018212217199
学术搜索中的文章